EF-2001
PB PROPOSAL
DATA

EFFECT

Anti-Tumour Effect

Anti-Allergy Effect

Intestinal Flora Improvement Effect

Comparison of Immunity-Specific Activity by Bacteria Type

Radioprotective Effect

Immunity-Boosting Effect

Intestinal Pathogen Preventative Effect

Edema Inhibitory Effect

Birth Defect Prevention Effect

Anti-diabetic Effect

Blood Pressure Elevation Inhibition and Improved Liver Function Effects

Cancer Treatment Clinic (1)

- Hyperthermic cancer treatment enhancing effect

- Hyperthermic treatment CT1

- Hyperthermic treatment CT2

- Hyperthermic treatment CT3

Radiotherapy Clinic (2)

- Combined effect with radiotherapy

- Radiotherapy CT1

- Radiotherapy CT2

- Radiotherapy CT3

- Radiotherapy CT4

- Radiotherapy CT5

Overview of Conference Presentations on Immunobiotic Lactic Acid Bacteria EF-2001

Overview of Theses on Immunobiotic Lactic Acid Bacteria EF-2001

COMPANY INFO.
TERM
PUBLICATIONS/VIDEOS

Intestinal pathogen (streptomycin-resistant E. coli) preventative effect in mice administered with EF-2001


Mice were administered feed containing 10% EF-2001 for a four-week period, then orally administered streptomycin-resistant (SM-resistant) exogenous E. coli bacteria. The number of SM-resistant E. coli bacteria in the excrement of the mice was measured.

* (n) = number of mice with SM-resistant E. coli bacteria found in their excrement



SM-resistant E. coli quickly disappeared from the excrement, indicating an intestinal pathogen preventative effect.


   

Copyright© 2013 NIHON BERUMU CO.,LTD ALL Rights Reserved